New drug combo tested for tough bile duct cancers
NCT ID NCT05712356
First seen May 26, 2026 · Last updated Jun 17, 2026 · Updated 6 times
Summary
This study tested a new drug called LSTA1 added to standard treatment for people with advanced bile duct or gallbladder cancer. The goal was to see if the combination is safe and works better than standard treatment alone. The trial was stopped early, and results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alliance for Multispecialty Research
Merriam, Kansas, 66204, United States
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center
Cincinnati, Ohio, 45219, United States
-
FirstHealth of the Carolinas, Inc.
Pinehurst, North Carolina, 28374, United States
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Northwell Health - Zuckerberg Cancer Center
Lake Success, New York, 11042, United States
-
Norton Cancer Institute, Audubon
Louisville, Kentucky, 40217, United States
-
Norton Cancer Institute, Downtown
Louisville, Kentucky, 40202, United States
-
Spartanburg Medical Center
Spartanburg, South Carolina, 29303, United States
-
Stony Brook Cancer Center
Stony Brook, New York, 11794, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Arizona Cancer Center
Tucson, Arizona, 85719, United States
-
University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
University of Kentucky Medical Center
Lexington, Kentucky, 40536, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.